Relit Biosciences gives patients access to biomarker-based imaging and radioligand therapy, the pairing of a diagnostic scan with a matched radioactive drug.
Relit Biosciences describes itself as a patient's access point to biomarker-based imaging and radiotherapeutics: theranostic scans that show whether a tumour carries a target such as PSMA or somatostatin receptors, and the radioligand therapies that follow. It is an Even One Ventures portfolio company; its public site is a single page with a contact address.
Shares Even One Ventures and the tags startup, evenone-portfolio, oncology.
Shares Even One Ventures and the tags startup, evenone-portfolio, oncology.
Shares Even One Ventures and the tags startup, evenone-portfolio, oncology.
Shares Even One Ventures and the tags startup, evenone-portfolio, oncology.
Shares Even One Ventures and the tags startup, evenone-portfolio, oncology.
Shares Even One Ventures and the tags startup, evenone-portfolio, oncology.
Shares Even One Ventures and the tags startup, evenone-portfolio.
Shares Even One Ventures and the tags startup, evenone-portfolio.